- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Morepen Labs plans to employ over 1000 professionals

Gurugram: Morepen Laboratories Ltd. has announced the addition of more than 1,000 professionals to its salesforce over the next three years, with over 200 team members expected to join in FY26 alone.
This is part of the Company's expansion plan that aims at deepening its connect with doctors, patients, pharmacies, and healthcare professionals across the country.
"Following consistently encouraging growth in the segment, this move marks a significant step in strengthening Morepen’s formulations business in the market reinforcing its commitment to building a stronger domestic footprint and aligning with India’s vision of affordable, accessible healthcare for all," the Company stated.
"This expansion represents a pivotal moment in Morepen’s journey as we sharpen our focus on the expanding domestic finished dosage market," said Mr. Sushil Suri, Chairman and Managing Director of Morepen Laboratories. "With the leadership in our high value APIs, this significant increase in our salesforce and enhanced reach to doctors, pharmacies, and patents, we are setting the stage for getting a bigger pie in the Indian pharmaceutcal market valued at ₹2.38 lakh crore, yielding higher gross margins and better returns for stakeholders in the long run.”
Currently, Morepen’s formulation business stands at approximately Rs 325 crore, and the company is targeting a Rs 1,000 crore finished dosages business within the next five years.
"This goal will be supported by an aggressive expansion of its medical representative network and deeper market penetration across urban and rural India, with major growth expected from new products that the company is already producing at highly competitive costs," Morepen empasizes.
The Indian pharmaceutical market is projected to reach $130 billion in 2030, with an expected annual growth rate of 8.2%.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story